Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
5.78
-0.12 (-2.03%)
At close: May 11, 2026, 4:00 PM EDT
5.82
+0.04 (0.69%)
After-hours: May 11, 2026, 7:57 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $901.13 million as of May 11, 2026. Its market cap has increased by 119.75% in one year.
Market Cap
901.13M
Enterprise Value
779.84M
1-Year Change
119.75%
Ranking
Category
Stock Price
$5.78
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $901.13M, an increase of 112.94%. That is a compound annual growth rate of 17.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 919.84M | 75.28% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 1.04B |
| Aktis Oncology | 1.03B |
| Sana Biotechnology | 1.00B |
| SELLAS Life Sciences Group | 989.09M |
| Lexicon Pharmaceuticals | 978.70M |
| Xencor | 973.48M |
| Design Therapeutics | 955.28M |
| Phathom Pharmaceuticals | 953.16M |